Table 4.
Levels of abnormal biochemical markers in preeclamptic and non-preeclamptic participants.
| Variables | Overall | Preeclamptic pregnancy | Non-preeclamptic pregnancy | p-value |
|---|---|---|---|---|
| TC (mg/dL) | 222.9 ± 64.3 | 276.1 ± 84.8 | 212.7 ± 56.5 | 0.001*** |
| TG (mg/dL) | 266.4 ± 139.6 | 310.1 ± 114.8 | 261.1 ± 145.2 | 0.234 |
| HDL-C (mg/dL) | 28.9 ± 12.5 | 21.2 ± 7.7 | 30.7 ± 12.7 | 0.008** |
| LDL-C (mg/dL) | 139.7 ± 64.6 | 192.8 ± 72.2 | 128.5 ± 58.8 | 0.000*** |
| ALT (U/L) | 36.3 ± 27.5 | 66.4 ± 26.6 | 30.4 ± 24.0 | 0.000*** |
| GGT (U/L) | 9.5 ± 7.4 | 7.1 ± 8.8 | 9.7 ± 7.1 | 0.299 |
| Uric acid (mg/dL) | 4.6 ± 1.4 | 6.0 ± 1.5 | 4.4 ± 1.1 | 0.000*** |
| Creatinine (mg/dL) | 0.5 ± 0.21 | 0.56 ± 0.48 | 0.54 ± 0.17 | 0.872 |
Data are presented as % or mean ± SD. p-values are obtained from Independent sample t-test in comparison between preeclamptic and non-preeclamptic groups. Values greater than the reference range are denoted as “elevated”44.
TC total cholesterol, TG triglyceride, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, ALT alanine aminotransferase, GGT gamma glutamyltransferase.
*p < 0.05; **p < 0.01; ***p < 0.001.